Skip to Main Content
Contribute Try STAT+ Today

A federal watchdog agency has issued an unusual warning to the pharmaceutical industry to avoid using kickbacks — specifically, under the guise of so-called speaker programs — to entice doctors to write more prescriptions.

In a special fraud alert, the Office of Inspector General at the Department of Health and Human Services strongly advised drug makers to think twice before rewarding high-prescribing physicians with speaking deals, conditioning speaking payments based on prescribing targets, or holding programs at venues — such as high-priced restaurants, wineries, or golf clubs — that are not conducive to education.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.